Page 9 - பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா பெரல்மேன் பள்ளி மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Full COVID Vaccine Approval Is Coming. But Is It Too Late? Pilar Melendez © Provided by The Daily Beast Pavlo GoncharGetty Images Half a year after wildly successful development of life-saving vaccines, the United States is closer than ever to getting one of its COVID-19 shots fully approved, as opposed to merely authorized for emergency use during a raging pandemic. The only problem is that the agency has been outrun by conspiracy theorists and, most recently, an extremely dangerous new variant. The U.S. Food and Drug Administration on Friday granted Pfizer and BioNTech priority review designation for their COVID-19 vaccination for individuals ages 16 and older. The vaccine was the first of the three currently available in the U.S. to be authorized for emergency use in December. The emergency grant, however, only cleared the way for the vaccine to be shipped to hospitals, clinics, and pharmacies to combat the deadly pandemic, as opposed to distributed and m

United statesNew yorkBaylor college of medicineGenevieve kanterPeter marksRochelle walenskyJanet woodcockPeter hotezCenters for diseaseUniversity of pennsylvania perelman school medicineDrug administration onNew york timesPavlo gonchar gettyDaily beast pavlo gonchargetty imagesDrug administrationBaylor college